The Claim
Among patients with Graves' disease undergoing radioactive iodine ablation, 74.5% are female and the median age at treatment is 48 years.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among people with Graves' disease who receive radioactive iodine treatment, about three out of four are women, and the typical age at treatment is 48 years.
See the scientific wording
Among patients with Graves' disease who undergo radioactive iodine ablation, the majority are female (74.5%), and the median age at treatment is 48 years, indicating a demographic pattern consistent with known epidemiology of the disease.
Women's immune systems are more likely to mistakenly attack the thyroid gland due to hormonal influences, and this attack becomes severe enough to require treatment around middle age when immune regulation changes.
What the research says
1 studyThis study looked at people who got radioactive iodine treatment for Graves' disease and found that most were women in their late 40s — just like the claim says. This matches what doctors already know: Graves' disease is more common in women around this age.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.